Stockreport

KalVista Pharmaceuticals: Looking To Be A Major Player In HAE [Seeking Alpha]

KalVista Pharmaceuticals, Inc.  (KALV) 
Last kalvista pharmaceuticals, inc. earnings: 3/10 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.kalvista.com
PDF Summary KalVista Pharmaceuticals, Inc. is advancing Sebetralstat, a potential first oral on-demand treatment for hereditary angioedema, with FDA approval expected in [Read more]